Today: 10 June 2026
Strategy’s $12.4B Bitcoin Loss Puts Its ‘Never Sell’ Bet Under Fresh Pressure
6 February 2026
2 mins read

Strategy’s $12.4B Bitcoin Loss Puts Its ‘Never Sell’ Bet Under Fresh Pressure

New York, Feb 6, 2026, 01:22 (EST)

  • Strategy reported a $12.4 billion net loss in the fourth quarter, dragged down by the plunge in bitcoin weighing on its asset values
  • The company reported holding 713,502 bitcoins as of Feb. 1, with an average purchase price of $76,052 per coin
  • Executives stood by the long-term plan despite sharp swings in the stock and crypto markets

Strategy, the bitcoin-focused company that used to be MicroStrategy, posted a $12.4 billion net loss for Q4, hit hard by the sharp plunge in crypto prices.

The numbers have gained new weight as accounting changes now cause bitcoin’s daily swings to impact reported earnings more sharply, ramping up volatility for firms holding crypto as a treasury asset. Investors are reevaluating the trade amid bitcoin’s pullback and persistent volatility in funding costs.

Bitcoin hovered near $63,140 as Strategy shares dipped in after-hours, Reuters reported. Executive chairman Michael Saylor told investors, “The actions by big finance, the actions by the big banks and the actions by the financial regulators are the fundamentals.” https://www.reuters.com/business/saylor-le…

Strategy reported holding 713,502 bitcoins as of Feb. 1, at a total cost of $54.26 billion, averaging $76,052 per bitcoin. President and CEO Phong Le revealed the company raised $25.3 billion in capital during 2025 and boosted its holdings, including a purchase of 41,002 bitcoins in January.

Strategy reported a $17.4 billion operating loss, which included an unrealized digital asset loss of the same amount. Revenue came in at $123.0 million. The company closed 2025 with $2.3 billion in cash and equivalents. CFO Andrew Kang highlighted a $2.25 billion “USD Reserve” set aside to cover dividends and interest for more than two years. https://www.businesswire.com/news/home/202…

CoinDesk reported that Strategy’s loss followed a steep bitcoin decline during the quarter. The stock plunged 17% on Thursday, tracking bitcoin’s slide toward the mid-$60,000s.

Bitcoin’s decline wiped out gains from the post-election bounce, the Financial Times reported, with risk assets falling and leveraged crypto bets being liquidated.

The selloff dragged down other crypto-linked stocks too. Coinbase and Robinhood took hits in the same wave as traders pulled back from the sector.

But the situation works both ways. Should bitcoin continue to drop and Strategy’s equity value slide toward—or even below—the market worth of its bitcoin holdings, raising new funds could become tougher, undermining the plan that depends on selling stock and other securities to acquire more bitcoin.

MarketWatch highlighted that Strategy’s stance of “don’t ever sell your bitcoin” is under pressure as its stock declines, noting the premium investors previously paid for its bitcoin exposure is narrowing. https://www.marketwatch.com/story/strategy…

Strategy has spent years growing its bitcoin holdings using a blend of operating cash, debt, and equity issuance, making its shares a volatile stand-in for the cryptocurrency. It’s now also offering preferred stock and various other instruments linked to its “bitcoin treasury” approach.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Super Micro (SMCI) stock slides 9% after earnings spike — what to watch before Friday’s trade
Previous Story

Super Micro (SMCI) stock slides 9% after earnings spike — what to watch before Friday’s trade

Ford stock slips before market open as EV sales dive and Geely talks linger
Next Story

Ford stock slips before market open as EV sales dive and Geely talks linger

Go toTop